Encompassing subjective, perceptual, and attitudinal experiences about one’s body and physical appearances (Cash,
2004; Thompson et al.,
2012), body image concerns have been referred to as a contemporary norm (Hosseini et al.,
2020; Rosen et al.,
1995). Body image distress is a risk factor for a range of negative outcomes including low self-esteem (Mellor et al.,
2010), depression (Stice,
2002;), eating disorders (Sadibolova et al.,
2019), and body dysmorphic disorder (Cooper & Osman,
2007; Veale,
2004). While there is considerable evidence for the efficacy of cognitive behavioural therapy (CBT) in decreasing body image concerns (e.g., Farrell et al.,
2006; Lewis-Smith et al.,
2016), there is a dearth of research looking at how specific cognitive processes may contribute to negative appearance evaluation (Linardon et al.,
2019). Metacognitive beliefs (i.e., beliefs people have about their cognitive processes) concerning the value of worry and rumination may be a useful addition, given that past research has identified such beliefs as a transdiagnostic factor in psychopathology, including body dysmorphia and eating disorders (e.g., Cooper & Osman,
2007; Donyavi et al.,
2015; Waine et al.,
2009; Wells,
2019). Accordingly, this study developed a questionnaire designed to assess metacognition regarding negative appearance evaluation; that is, one’s metacognitive beliefs about physical appearance.
Theoretical Framework
Elevated metacognitions have been identified across a variety of psychological conditions and problem behaviours (Normann & Morina
2018; Wells
2019). Metacognition can be described as any knowledge or cognitive processes involved in the control, appraisal, monitoring and regulation of cognition (Wells & Matthews
1994,
1996). Wells and Matthew (
1994,
1996) developed the transdiagnostic Self-Regulatory Executive Function Model (S-REF), which accounts for the universal role of metacognitive beliefs (i.e., metacognitions) in psychopathology. Beliefs, as outlined by Fodor (
1983) and Quine and Ullian (
1970), do not exist in isolation but rather form interconnected networks that shape cognitive processes (Connors & Halligan,
2015). These conceptualisations align with the S-REF model, which posits that metacognitive beliefs play a central role in maintaining cognitive attentional syndromes (CAS). While Fodor emphasizes the complexity of studying high-level beliefs, the S-REF model offers a framework for operationalising these beliefs by examining their influence on cognitive processes including forms of repetitive negative thinking, such as worry and rumination (Wells,
2009; Wells & Capoianco;
2020). Central to the S-REF is the principle that psychological problems/distress are caused by Cognitive Attentional Syndrome (CAS), an inflexible attentional processing style that comprises worry, rumination, threat monitoring, and self-regulation strategies that maintain perseverative negative thinking patterns. The CAS results from biased positive and negative metacognitions (Wells & Matthew,
1994,
1996). Positive metacognitive beliefs concern the usefulness of the CAS and the need to engage in cognitive activities such as worry or rumination (e.g., “If I worry, I will be prepared”, “Focusing on danger will keep me safe”). Conversely, negative metacognitive beliefs focus on the dangerousness, meaning, importance, or uncontrollability of thoughts or cognitive activities, such as worry or rumination (e.g., “I have no control over my thoughts”, “Worrying can harm me”) (Wells,
2009). Metacognitive beliefs about appearance play a dual role in both the aetiology and maintenance of psychopathologies such as Body Dysmorphic Disorder (BDD) and eating disorders. In the early stages of these disorders, positive metacognitive beliefs (e.g., ‘Worrying about my appearance will help me feel prepared or in control’) may contribute to the onset of maladaptive behaviours, while negative metacognitive beliefs (‘I cannot control my thoughts about my appearance’) are more likely to maintain these behaviours by perpetuating rumination and distress.
Previous Measures
Traditionally, frequently used measures for assessing metacognition in problem behaviours and psychological disorders are the self-report Metacognitions Questionnaire (MCQ; Cartwright-Hatton & Wells,
1997) and the shorter MCQ-30 (Wells & Cartwright-Hatton,
2004). Both MCQs are based on the S-REF model and assess five dimensions of dysfunctional metacognitive beliefs namely positive beliefs about worry; negative beliefs about uncontrollability of thoughts and corresponding danger; cognitive confidence; negative beliefs about thoughts in general; and cognitive self-consciousness. Research has supported strong links between metacognitive beliefs, as measured by the MCQs, and psychopathologies. For example, in their metanalysis, Sun et al. (
2017) looking at 47 studies found increased levels of metacognitive beliefs in individuals (
N = 3772) with eating disorder, generalised anxiety disorder, major depressive disorder, obsessive-compulsive disorder, and schizophrenia compared to healthy control individuals (
N = 3376). These findings suggest that metacognitive beliefs are transdiagnostic and that negative evaluation of one’s mental state is an important consideration when looking at problem behaviours and psychological disorders (Sun et al.
2017).
A growing number of metacognitive measures have been developed and validated for specific disorders or problem behaviours (e.g., gambling, Spada et al.,
2015; alcohol use, Spada & Wells,
2008; rumination, Kolubnski et al,
2017; Papageorgiou & Wells,
2003; health anxiety, Bailey & Wells,
2015; anger, Moeller et al.,
2019; and insomnia, Waine et al.,
2009) to enable sensitive assessment of unique cognitive processes, improve validity, and support targeted intervention (Spada & Wells,
2008; Wells,
2000,
2009). While metacognition has been explored in conditions with a body image component such as eating disorders (Aloi et al.,
2020), obesity (Woolrich et al.,
2008), and body dysmorphic disorder (Donyavi et al.,
2015; Nikfarjam et al.,
2015), no metacognitive measure relating specifically to physical appearance currently exists.
To date, psychometric tools have focused primarily on three dimensions of body image: subjective and affective measures of body (dis)satisfaction or disturbances relating to global and/or specific self-evaluation of appearance (Shroff et al.,
2009; Thompson et al.,
1999); behavioural aspects of body image such as avoidance of situations or body checking behaviours (Kling et al.,
2019; Shroff et al.,
2009); and cognitive aspects of body image that aim to evaluate thoughts and beliefs about one’s appearance (Shroff et al., Kling et al.,
2019). The focus has largely been on the content of thoughts about one’s appearance rather than actual beliefs about cognitive processes (i.e., metacognitive beliefs) such as needing to engage in worry about one’s appearance, despite the latter playing an important role in appearance-related concerns. Development of a measure which specifically taps into metacognitive beliefs regarding appearance will assist researchers and clinicians to understand core factors related to body image distress, and can be used with existing clinical measures as part of a comprehensive battery of scales.
The Current Study
Appearance beliefs are an important contemporary issue due to the impact negative body image has on self-perception and psychological wellbeing. To effectively research expanding conceptualisations of appearance and body image, reliable and valid assessment measures are required, particularly in the context of assessing and treating psychopathology associated with the transdiagnostic construct of physical appearance concerns (e.g., body dysmorphia, eating disorders). Accordingly, the overarching goal of the current study was to develop and evaluate the psychometric properties of a new measure, the Metacognitions about Physical Appearance Questionnaire (MPAQ), which assesses metacognitive beliefs about worry or rumination on physical appearance and the importance of such thoughts and cognitive processes, across two independent samples. To meet this aim, the following steps were planned: (1) thematic analysis of reports from clinicians regarding metacognitive beliefs about appearance to assist with generating an item pool before obtaining feedback from experts and laypeople; (2) exploratory factor analyses to gauge the underlying structure of the MPAQ and assess items for reduction; (3) conduct confirmatory factor analysis and assess the suitability of fit indices; (4) evaluate the reliability of the MPAQ using Cronbach’s alpha, composite reliability, and McDonald’s ω; (5) investigate the convergent validity of the MPAQ by examining possible associations with existing measures of metacognitive beliefs, body image concern, rumination, appearance orientation, and frequency of worry; (6) investigate discriminant validity against theoretically distinct constructs including cognitive confidence and positive appearance evaluation; and (7) examine the incremnetal validity of the MPAQ by exploring predictive relationships with depression, anxiety, and stress.
Discussion
The present study aimed to develop and test the psychometric properties of a scale measuring metacognitions about physical appearance, the MPAQ. Overall, results revealed that the MPAQ had a clear factor structure and two theoretically driven subscales. Reliability and validity of the scale were supported, suggesting the MPAQ is a psychometrically sound measure. A panel of experts, a review of the existing literature and current metacognitive measures (e.g., Cartwright-Hatton & Wells,
1997; Wells & Cartwright-Hatton,
2004; Cooper & Osman,
2007; Nikfarjam et al.,
2015), and thematic analysis (see Wells & Matthews,
1994) was used to develop the initial 30-item MPAQ. As supported by the literature (e.g., Bornstein,
1996; Matsunaga,
2010) the item pool was purposely expansive to maximise face validity and avoid missing important aspects of metacognitive beliefs related to physical appearance. Congruent with the initial thematic analysis, the final 15-item, two-factor solution of the MPAQ aligned with theory-driven expectations (i.e., positive and negative metacognitive beliefs; Wells,
2000). However, upon review of the S-REF model (Wells & Matthews,
1996) and the MCQ and MCQ-30 (Cartwright-Hatton & Wells,
1997; Wells & Cartwright-Hatton,
2004), it is plausible that many of the removed items represented metacognitive factors other than positive and negative beliefs such as cognitive self-consciousness or cognitive control. Considering that the items were generated from thematic analysis of clinicians’ reports regarding common metacognitive beliefs for those with body image concerns, it is plausible that positive and negative metacognitive beliefs about physical appearance are pertinent dysfunctional forms of cognition for this population. This idea is mirrored in a meta-analysis by Sun and colleagues (
2017) who found moderate-to-large effects for negative and positive metacognitions across psychopathologies. It remains unclear if positive or negative metacognitive beliefs about appearance may vary in strength and dysfunction across different types of body image and eating disorder difficulties, highlighting avenues for future research.
Internal reliability of the MPAQ was tested with Cronbach’s alpha. Cronbach’s alpha has been criticised as providing the lower-bound estimate for the composite score reliability, thus underestimating true reliability (Hayes & Coutts,
2020; Peterson & Kim,
2013). Hence, composite reliability coefficients and McDonald’s Omega were also included to test the internal reliability of the scale. All three tests confirmed good to excellent internal reliability of the MPAQ and its’ subscales.
Findings also supported the convergent validity of the MPAQ. Specifically, convergent validity of the MPAQ and its subscales was supported in both samples with moderate correlations demonstrated between the MPAQ and the MCQ-30, MPAQ-PB and MCQ-30 positive belief about worry, and MPAQ-NB and MCQ-30 negative beliefs about uncontrollability and danger of worry. Significant associations were also observed between the MPAQ and BICI, RRQ, appearance orientation subscale of the MBSRQ, frequency of worry, and the DASS. Strong correlations between the BICI and MPAQ were anticipated due to their conceptual overlap. While the MPAQ focuses on metacognitive beliefs about appearance-related worry, the BICI assesses concerns related to physical dissatisfaction and dysmorphic features. Correlations were selectively run between the full MPAQ and some measures, and between subscales and others, based on the conceptual relevance of the constructs. For instance, the positive beliefs subscale of the MPAQ was correlated with the MCQ-30 (POS) due to their shared focus on positive metacognitive beliefs. Similarly, the full MPAQ was compared to the BICI and the DASS, given that both measures capture broader concerns about physical appearance. This approach was intended to reflect the alignment between specific aspects of the MPAQ and corresponding constructs in other measures. The findings are collectively supported by literature which has found that negative body image is strongly linked to the development of body dysmorphia (e.g., Rosen et al.,
1995; Veale,
2004), rumination (Etu & Gray,
2010), and appearance evaluation (Cash,
1994).
Discriminant validity was demonstrated across both samples. The MPAQ-PB and MPAQ-NB were both distinct from cognitive confidence (MCQ-CC), cognitive self-consciousness (MCQ-CSC), and appearance evaluation. In Sample 1, the weak correlation with cognitive self-consciousness suggests some overlap in cognitive processes such as self-awareness. However, the MPAQ remains distinct in its focus on metacognitive beliefs related to appearance. In Sample 2, the MPAQ demonstrated a moderate negative correlation with appearance evaluation, indicating that metacognitive beliefs about physical appearance are distinct from positive evaluations of one's appearance; and that individuals with higher appearance-related metacognitive concerns tend to have less positive evaluations of their appearance. The similarity in content between MPAQ and appearance evaluations may indicate that such appraisals are more ego-syntonic and self-focused, consistent with metacognitive theory, where negative beliefs are more prominent than positive ones. Given the smaller correlations observed with the MPAQ-PB subscale, these findings should be interpreted cautiously, as they may reflect less robust discriminant validity for this subscale. Further research could investigate the specific metacognitive processes captured by the MPAQ-PB in both clinical and non-clinical populations. No data was available for these constructs in Sample 1 and thus this relationship should be replicated in future studies.
Finally, incremental validity was demonstrated as the MPAQ explained additional variance in depression, anxiety, and stress across both samples, beyond what was accounted for by the MCQ-30. This supports the notion that appearance-related metacognitive beliefs have a significant impact on mental health outcomes. This finding aligns with past research, which has shown that negative body image and appearance-related concerns are closely tied to poor mental health outcomes (e.g., Cash et al.,
2004; Etu & Gray,
2010; Ivarsson et al.,
2006; Satghara et al.,
2019; Stice,
2002). For example, Cash and colleagues (
2004) found that negative body image was associated with social-evaluation anxiety and intimacy anxiety in women. Similarly, stress has been linked to negative body image in adolescents (Murray et al.,
2013), and numerous studies have demonstrated a strong connection between negative body image and depression (e.g., Manaf et al.,
2016; Rierdan et al.,
1989; Stice,
2002; Stice et al.,
2000). Importantly, the MPAQ showed incremental validity by explaining additional variance in depression, anxiety, and stress, beyond that explained by the MCQ-30. This suggests that the MPAQ captures unique aspects of metacognitive beliefs about appearance that contribute to mental health outcomes, making it a valuable tool for understanding how appearance-related worries specifically impact psychological well-being.
Theoretical and Practical Implications
The current study suggests that the MPAQ is a reliable and valid measure. The MPAQ may provide further insight concerning metacognitive processes implicated in appearance related concerns and guide future research, clinical assessments, and therapeutic interventions in those populations where appearance related concerns contribute to psychological distress. Research suggests that metacognitions are central in understanding appearance related disorders such as body dysmorphic disorder (e.g., Cooper & Osman,
2007; Donyavi et al.,
2015) and eating disorders (e.g., Olstad et al.,
2015). Individuals scoring high on the MPAQ may benefit from metacognitive therapy (Wells,
2009); however, this needs further research.
The findings of the current study also have theoretical implications. The two subscales of the MPAQ measuring positive and the negative beliefs about physical appearance corroborates the S-REF theory (Wells,
2000). Particularly, positive beliefs can be seen as activating the CAS and the need to engage in worry or ruminations while negative beliefs maintain and exacerbate the CAS by focusing on the danger or uncontrollability or worry and rumination (Spada et al.,
2015; Wells,
2000). Collectively this suggests that metacognitive beliefs are present and relevant in physical appearance concerns.
Strengths, Limitations, and Future Directions
The current study was strengthened by two large independent samples, which had sufficient power, minimising the margin of error around estimates (Faber & Fonseca,
2014). To the authors’ knowledge, this is also that first known measure of metacognition about physical appearance that may be a valuable transdiagnostic measure in disorders where appearance related metacognitions are implicated. The MPAQ is a brief and easy to administer, free self-report measure which could be used by clinicians, researchers, and other health professionals to inform assessments related to individuals’ physical appearance concerns.
This study was limited by using two cross-sectional homogenous samples composed largely of Caucasian females over the age of 18 years. Consequently, caution should be exercised when generalising to different ethnic groups and males. Further validation of the MPAQ is recommended in male samples, diverse ethnicities, and clinical samples (e.g., individuals diagnosed with eating disorder or body dysmorphic disorder). The use of a cross-sectional correlational design also meant we were unable to examine test-retest reliability of the MPAQ and the temporal precedence among related constructs, establishing concurrent rather than predictive validity. It is recommended that future studies include a longitudinal element to examine both the consistency of the MPAQ over time and predicative validity with additional ancillary measures of metacognition, body image concern, and psychological distress. Unfortunately, measurement invariance was not considered in the current study and represents a consideration for future research.
Although the expert panel was not consulted again after the items were generated, the items were grounded in robust qualitative feedback from experienced clinicians, ensuring relevance and alignment with clinical themes. To further validate the content of the items, future research could engage expert panels to review and refine the generated items, ensuring that they fully capture the identified themes. Finally, the study was limited by using a long survey packed without attention checks which may have caused responder fatigue and thus impacted the internal validity of the study.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.